Novo Nordisk's brand name for its 20% R/neutral and 80% NPH/isophane crystal insulin which is intermediate-acting. Another comparable insulin, also Novo-made was Mixtard 20. Eli Lilly produced a comparable insulin called Humulin M2; it was discontinued in the EU & UK in July, 2004.